TREAT vs IMX: A Comparative Analysis of Novel Therapies for Inflammatory Bowel Disease

The article provides a comparative analysis of TREAT and IMX, two emerging crypto assets in the context of investments for inflammatory bowel disease therapies. It aims to assist investors in evaluating which token presents a better buying opportunity by exploring their price histories, supply mechanisms, institutional adoption, and technical developments. Focused on both short and long-term predictions, the article also highlights investment strategies, market and technical risks, and regulatory considerations. It caters to new, experienced, and institutional investors, facilitating informed decisions in the volatile cryptocurrency market. View real-time prices for TREAT and IMX on Gate.

Introduction: TREAT vs IMX Investment Comparison

In the cryptocurrency market, the comparison between TREAT and IMX has always been a topic that investors cannot ignore. The two not only have significant differences in market cap ranking, application scenarios, and price performance, but also represent different positioning in crypto assets.

TREAT (TREAT): Launched as the final token in the Shiba Inu Ecosystem, it's designed to provide transactional rewards and access to advanced technologies within the Shiba Network State.

IMX (IMX): Introduced as a Layer 2 scaling solution for NFTs on Ethereum, offering instant transactions, scalability, and zero gas fees for minting and trading.

This article will comprehensively analyze the investment value comparison between TREAT and IMX, focusing on historical price trends, supply mechanisms, institutional adoption, technical ecosystems, and future predictions, attempting to answer the question investors care most about:

"Which is the better buy right now?"

I. Price History Comparison and Current Market Status

  • 2025: TREAT reached an all-time high of $0.04551 on January 14, 2025.
  • 2025: IMX experienced significant volatility, dropping from its all-time high of $9.52 in 2021 to a low of $0.299164 on November 22, 2025.
  • Comparative analysis: In the current market cycle, TREAT has fallen from its peak of $0.04551 to $0.0006359, while IMX has declined from $9.52 to $0.3193.

Current Market Situation (2025-11-25)

  • TREAT current price: $0.0006359
  • IMX current price: $0.3193
  • 24-hour trading volume: TREAT $24,291.83 vs IMX $77,755.74
  • Market Sentiment Index (Fear & Greed Index): 20 (Extreme Fear)

Click to view real-time prices:

price_image1 price_image2

II. Core Factors Affecting Investment Value of TREAT vs IMX

Supply Mechanism Comparison (Tokenomics)

  • TREAT: DaVinci (Shibarium developer) has clarified that any TREAT token listings are unrelated to official Shibarium development, suggesting caution regarding its tokenomics
  • IMX: Limited information available in the provided context
  • 📌 Historical pattern: No specific data provided on how supply mechanisms drive price cycle changes

Institutional Adoption and Market Applications

  • Institutional holdings: Insufficient data to determine which is more favored by institutions
  • Enterprise adoption: Limited information available on cross-border payment, settlement, and portfolio applications
  • National policies: No specific regulatory attitudes from different countries mentioned

Technical Development and Ecosystem Building

  • SYNC Network provides a comparable DeFi ecosystem example with crypto bonds (NFTs) that earn interest when staked with liquidity pairs
  • Decentralized finance (DeFi) projects utilize staking and liquidity proof mechanisms to build trustless economic systems
  • Ecosystem comparison: Limited specific information on DeFi, NFT, payment, or smart contract implementation for TREAT or IMX

Macroeconomic and Market Cycles

  • Performance in inflationary environments: Insufficient data to determine which has better anti-inflation properties
  • Macroeconomic monetary policy: No specific information on how interest rates or the dollar index affect either token
  • Geopolitical factors: No information provided on cross-border transaction demands or international situations

III. 2025-2030 Price Prediction: TREAT vs IMX

Short-term Prediction (2025)

  • TREAT: Conservative $0.000559592 - $0.0006359 | Optimistic $0.0006359 - $0.000858465
  • IMX: Conservative $0.174042 - $0.3223 | Optimistic $0.3223 - $0.344861

Mid-term Prediction (2027)

  • TREAT may enter a growth phase, with estimated prices ranging from $0.0007314916675 to $0.0009862809
  • IMX may enter a steady growth phase, with estimated prices ranging from $0.3265753095 to $0.5173833555
  • Key drivers: Institutional capital inflow, ETF developments, ecosystem growth

Long-term Prediction (2030)

  • TREAT: Base scenario $0.00098545899925 - $0.00122196915907 | Optimistic scenario $0.00122196915907 - $0.001661878056335
  • IMX: Base scenario $0.413477971745107 - $0.590682816778725 | Optimistic scenario $0.590682816778725 - $0.850583256161364

View detailed price predictions for TREAT and IMX

Disclaimer: The above predictions are based on historical data and market analysis. Cryptocurrency markets are highly volatile and subject to rapid changes. These projections should not be considered as financial advice or guarantees of future performance.

TREAT:

年份 预测最高价 预测平均价格 预测最低价 涨跌幅
2025 0.000858465 0.0006359 0.000559592 0
2026 0.000896619 0.0007471825 0.00061268965 17
2027 0.0009862809 0.00082190075 0.0007314916675 29
2028 0.0010668271735 0.000904090825 0.00075039538475 42
2029 0.00145847931889 0.00098545899925 0.00063069375952 54
2030 0.001661878056335 0.00122196915907 0.000647643654307 92

IMX:

年份 预测最高价 预测平均价格 预测最低价 涨跌幅
2025 0.344861 0.3223 0.174042 1
2026 0.4002966 0.3335805 0.296886645 4
2027 0.5173833555 0.36693855 0.3265753095 14
2028 0.5261715337725 0.44216095275 0.2874046192875 38
2029 0.6971993902962 0.48416624326125 0.305024733254587 51
2030 0.850583256161364 0.590682816778725 0.413477971745107 85

IV. Investment Strategy Comparison: TREAT vs IMX

Long-term vs Short-term Investment Strategies

  • TREAT: Suitable for investors focused on ecosystem potential and speculative growth
  • IMX: Suitable for investors interested in NFT and gaming markets, seeking Layer 2 scaling solutions

Risk Management and Asset Allocation

  • Conservative investors: TREAT: 5% vs IMX: 10%
  • Aggressive investors: TREAT: 15% vs IMX: 25%
  • Hedging tools: Stablecoin allocation, options, cross-currency portfolios

V. Potential Risk Comparison

Market Risks

  • TREAT: High volatility, speculative nature of meme coins
  • IMX: Dependence on NFT market trends, competition from other Layer 2 solutions

Technical Risks

  • TREAT: Ecosystem development uncertainty, potential smart contract vulnerabilities
  • IMX: Scalability challenges, network stability during high-traffic periods

Regulatory Risks

  • Global regulatory policies may impact both tokens differently, with meme coins potentially facing stricter scrutiny

VI. Conclusion: Which Is the Better Buy?

📌 Investment Value Summary:

  • TREAT advantages: Part of the Shiba Inu ecosystem, potential for speculative gains
  • IMX advantages: Established Layer 2 solution for NFTs, zero gas fees for minting and trading

✅ Investment Advice:

  • New investors: Consider a small allocation to IMX as an entry point to NFT-related assets
  • Experienced investors: Balanced approach with higher allocation to IMX, smaller position in TREAT for diversification
  • Institutional investors: Focus on IMX for its established infrastructure in the NFT space

⚠️ Risk Warning: The cryptocurrency market is highly volatile, and this article does not constitute investment advice. None

VII. FAQ

Q1: What are the main differences between TREAT and IMX? A: TREAT is the final token in the Shiba Inu Ecosystem, designed for rewards and access to advanced technologies within the Shiba Network State. IMX is a Layer 2 scaling solution for NFTs on Ethereum, offering instant transactions, scalability, and zero gas fees for minting and trading NFTs.

Q2: Which token has performed better in terms of price history? A: Based on the available data, IMX has shown more significant price movement, reaching an all-time high of $9.52 in 2021, compared to TREAT's all-time high of $0.04551 in 2025. However, both tokens have experienced substantial declines from their peak prices.

Q3: What are the current prices and trading volumes for TREAT and IMX? A: As of 2025-11-25, TREAT's price is $0.0006359 with a 24-hour trading volume of $24,291.83. IMX's price is $0.3193 with a 24-hour trading volume of $77,755.74.

Q4: How do the future price predictions compare for TREAT and IMX? A: For 2030, TREAT's base scenario predicts a range of $0.00098545899925 - $0.00122196915907, while IMX's base scenario predicts $0.413477971745107 - $0.590682816778725. IMX is projected to have higher absolute prices, but both tokens are expected to show growth.

Q5: What are the main investment strategies for TREAT and IMX? A: TREAT is suitable for investors focused on ecosystem potential and speculative growth, while IMX is better for those interested in NFT and gaming markets seeking Layer 2 scaling solutions. Conservative investors might allocate 5% to TREAT and 10% to IMX, while aggressive investors might consider 15% for TREAT and 25% for IMX.

Q6: What are the primary risks associated with investing in TREAT and IMX? A: TREAT risks include high volatility and the speculative nature of meme coins. IMX risks involve dependence on NFT market trends and competition from other Layer 2 solutions. Both face potential regulatory risks, with meme coins possibly facing stricter scrutiny.

Q7: Which token is considered the better buy for different types of investors? A: New investors might consider a small allocation to IMX as an entry point to NFT-related assets. Experienced investors could take a balanced approach with a higher allocation to IMX and a smaller position in TREAT for diversification. Institutional investors may focus on IMX for its established infrastructure in the NFT space.

* The information is not intended to be and does not constitute financial advice or any other recommendation of any sort offered or endorsed by Gate.